Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Last Chance To Influence Changes To NICE Methods & Processes In England

Executive Summary

Companies selling gene therapies and other high-cost, long-term treatments may be disappointed but unsurprised to learn that NICE will not immediately introduce any change to discount rates, which are used in health technology appraisals to better understand the long-term costs and benefits.

You may also be interested in...



Search Over For New Chief For England’s NICE

NICE, which is seen as a global leader when it comes to assessing the clinical and cost effectiveness of health care products, has appointed Samantha Roberts as its third chief executive in its over 20-year history.

England’s NICE To Find New Chief As Leng Announces Retirement

The top job at the National Institute for Health and Care Excellence has been described as one of the most challenging and potentially controversial roles in British public life.

England’s NICE To Find New Chief As Leng Announces Retirement

The top job at the National Institute for Health and Care Excellence has been described as one of the most challenging and potentially controversial roles in British public life.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS144820

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel